BiogenesisBago SA
Biotechnology ResearchBuenos Aires, Argentina1001-5000 Employees
BiogenesisBago SA is a biotechnology research company based in Garín, Buenos Aires, Argentina, that develops, produces and commercializes products for animal health. It operates in the biotechnology sector and employs between 1,001 and 5,000 people. The company maintains a corporate website at https://biogenesisbago.com. Its recent activity includes international vaccine-related collaborations and procurement arrangements, such as a 2026 distribution agreement with Onderstepoort Biological Products to stabilize long-term vaccine supply, and contracts awarded in 2025 by Canadian public agencies to supply vaccine products and contribute to Canada's first FMD vaccine bank. The company reports annual revenue in the range of $100 million to $250 million.